Short interest in Intellia Therapeutics Inc (NASDAQ:NTLA) decreased during the last reporting period, falling from 16.36M to 16.15M. This put 18.06% of the company's publicly available shares short.

Short interest for Intellia Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Intellia Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 3.32M shares traded per day, it would take 4.86 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.